Abbott Laboratories - 39 Year Dividend History | ABT
Historical dividend payout and yield for Abbott Laboratories (ABT) since 1985. The current TTM dividend payout for Abbott Laboratories (ABT) as of April 19, 2024 is $2.20. The current dividend yield for Abbott Laboratories as of April 19, 2024 is 2.09%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$182.663B |
$40.109B |
|
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
